These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

23 related articles for article (PubMed ID: 39088731)

  • 1. Adherence to antiretroviral therapy and its association with quality of life among people with HIV in the United States.
    Tadese BK; Hennessy F; Salmon P; Holbrook T; Prajapati G
    AIDS Care; 2024 Aug; ():1-13. PubMed ID: 39159289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preference for long-acting injectable for ART and PrEP among people with and without HIV: a cross-sectional study in Argentina.
    Sciannameo S; Zalazar V; Spadaccini L; Duarte M; Cahn P; Aristegui I; Sued O
    Ther Adv Infect Dis; 2024; 11():20499361241228341. PubMed ID: 38380160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient Attitudes Toward Self- or Partner-, Friend-, or Family-Administered Long-acting Injectable Antiretroviral Therapy: A Mixed-Methods Study Across 3 Urban Human Immunodeficiency Virus Clinics.
    Collins LF; Koester KA; McNulty MC; Montgomery ET; Johnson MO; Neilands TB; Dilworth SE; Sauceda JA; Dance K; Erguera X; Diaz Tsuzuki M; Gutierrez JI; Christopoulos KA; Colasanti JA
    Open Forum Infect Dis; 2024 Jun; 11(6):ofae265. PubMed ID: 38854389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multisite Study of Women Living With HIV's Perceived Barriers to, and Interest in, Long-Acting Injectable Antiretroviral Therapy.
    Philbin MM; Parish CL; Kinnard EN; Reed SE; Kerrigan D; Alcaide ML; Cohen MH; Sosanya O; Sheth AN; Adimora AA; Cocohoba J; Goparaju L; Golub ET; Fischl M; Metsch LR
    J Acquir Immune Defic Syndr; 2020 Jul; 84(3):263-270. PubMed ID: 32530905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient and Physician Preferences for Regimen Attributes for the Treatment of HIV in the United States and Canada.
    Gelhorn H; Garris C; Arthurs E; Spinelli F; Cutts K; Chua GN; Collacott H; Lebouché B; Lowman E; Rice H; Heidenreich S
    J Pers Med; 2022 Feb; 12(3):. PubMed ID: 35330334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain.
    Moreno C; Izquierdo R; Alejos B; Hernando V; Pérez de la Cámara S; Peraire J; Macías J; Bernal E; Albendín-Iglesias H; Alcaraz B; Suárez-García I; Moreno S; Jarrín I;
    AIDS Patient Care STDS; 2024 Jul; 38(7):305-314. PubMed ID: 38916077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review.
    Kanazawa JT; Saberi P; Sauceda JA; Dubé K
    AIDS Res Hum Retroviruses; 2021 Feb; 37(2):75-88. PubMed ID: 33176429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Barriers to Uptake of Long-Acting Antiretroviral Products for Treatment and Prevention of Human Immunodeficiency Virus (HIV) in High-Income Countries.
    Cooper SE; Rosenblatt J; Gulick RM
    Clin Infect Dis; 2022 Nov; 75(Suppl 4):S541-S548. PubMed ID: 36410385
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Considerations for long-acting antiretroviral therapy in older persons with HIV.
    O'Shea JG; Cholli P; Heil EL; Buchacz K
    AIDS; 2023 Dec; 37(15):2271-2286. PubMed ID: 37965737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic review of the values and preferences regarding the use of injectable pre-exposure prophylaxis to prevent HIV acquisition.
    Lorenzetti L; Dinh N; van der Straten A; Fonner V; Ridgeway K; Rodolph M; Schaefer R; Schmidt HA; Baggaley R
    J Int AIDS Soc; 2023 Jul; 26 Suppl 2(Suppl 2):e26107. PubMed ID: 37439057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Who wants long-Acting injectable antiretroviral therapy? Treatment preferences among adults with HIV in Florida.
    Fisk-Hoffman RJ; Liu Y; Somboonwit C; Widmeyer M; Canidate S; Prosperi M; Cook RL
    AIDS Care; 2024 Aug; ():1-10. PubMed ID: 39088731
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.